Vectorite Biomedical Inc.
4170
Rank in Stocks
#27613
Vectorite Biomedical Inc., established in 1993 and based in New Taipei City,... Vectorite Biomedical Inc., established in 1993 and based in New Taipei City, Taiwan, is a biotechnology firm dedicated to research and development activities globally, including a strong presence in its home country. The company's operations encompass the manufacturing of specialized cell preparation products, in addition to providing full-spectrum services for the collection, processing, and secure storage management of immune cells. These advanced cellular preparations are vital for applications in the medical fields of infectious diseases, inflammatory conditions, and various oncological and tumor-related illnesses.
Share Price
$0.32618371
Last synced: 2026-11-10
Market Cap
$14.28M
Change (1 day)
-2.28%
Change (1 year)
-28.30%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Vectorite Biomedical Inc. (4170)
Category
Healthcare
EPS for Vectorite Biomedical Inc. (4170)
EPS as of June 2026 TTM: $0.08
According to Vectorite Biomedical Inc.'s latest financial reports, its current EPS (TTM) is $0.08. At the end of 2025 the company had an EPS of $0.07, an increase over its 2024 EPS of $-0.03.
EPS history for Vectorite Biomedical Inc. from 2010 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.08 | 19.14% |
| 2025 | $0.07 | -350.36% |
| 2024 | $-0.03 | 471.43% |
| 2023 | 0.00 | -75.00% |
| 2022 | $-0.02 | -336.14% |
| 2021 | $0.01 | -109.96% |
| 2020 | $-0.08 | 16.50% |
| 2019 | $-0.07 | 204.26% |
| 2018 | $-0.02 | -55.07% |
| 2017 | $-0.05 | -16.05% |
| 2016 | $-0.06 | 12.66% |
| 2015 | $-0.06 | -316.86% |
| 2014 | $0.03 | -175.44% |
| 2013 | $-0.03 | -91.74% |
| 2012 | $-0.41 | 761.05% |
| 2011 | $-0.05 | 55.74% |
| 2010 | $-0.03 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | 18,676.98% |
US
|
|
| $-7.07 | -8,577.22% |
US
|
|
| $-5.29 | -6,442.93% |
AU
|
|
| $12.88 | 15,343.76% |
BE
|
|
| $21.56 | 25,751.32% |
NL
|
Questions about Vectorite Biomedical Inc.'s earnings per share (EPS)
What is Vectorite Biomedical Inc.'s earnings per share (EPS)?
Vectorite Biomedical Inc.'s earnings per share (EPS) over the last twelve months is $0.08, as of Jun 2026.
What was Vectorite Biomedical Inc.'s earnings per share (EPS) in 2025?
In 2025, Vectorite Biomedical Inc.'s earnings per share (EPS) was $0.07, compared with $-0.03 in 2024.
How has Vectorite Biomedical Inc.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Vectorite Biomedical Inc.'s earnings per share (EPS) was highest in 2025 ($0.07) and lowest in 2020 ($-0.08).
How does Vectorite Biomedical Inc.'s earnings per share (EPS) compare with similar companies?
Vectorite Biomedical Inc.'s earnings per share (EPS) ($0.08) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.